About MetaGuideX Ltd

A low-cost assay to detect multiple early-stage cancers from just one millilitre of blood for better decisions on referral in primary care, save lives and to help pharma access patients earlier.

Following the success of three accelerator programmes we have clinical validation of this assay and more novel IP in the pipeline for wider disease indications and metastatic therapy, all developed on non-diluting funds.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Headquarter
Gipsy Lane, Bioinnovation Hub, Oxford, Oxfordshire OX3 0BP, GB
description icon
Founded
2020

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more